Back to search
FDAFDA · Food and drugs·Recall number D-1222-2019

Lidocaine 1% - Sodium Bicarb 8.4% 10:1, 10 mL syringe, For Intradermal Use Only, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.

Published May 1, 2019 · Recall initiated: April 12, 2019

Summary

FDA records drug Class II recall D-1222-2019, published May 1, 2019 and initiated April 12, 2019. Recalling firm: CMC Enterprise Pharmacy; Status: Terminated; Reported quantity: 40 syringes; Lot: Lots: ED051902 Exp. 4/14/2019; ED101902 Exp. 4/19/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
CMC Enterprise Pharmacy
Distributor
NC
Lot
Lots: ED051902 Exp. 4/14/2019; ED101902 Exp. 4/19/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine 1% - Sodium Bicarb 8.4% 10:1, 10 mL syringe, For Intradermal Use Only, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208. recalled?

Yes. FDA published recall D-1222-2019 on May 1, 2019. Reported hazard: Lack of sterility assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter